高等学校化学学报 ›› 2012, Vol. 33 ›› Issue (02): 243.doi: 10.3969/j.issn.0251-0790.2012.02.006

• 研究论文: 无机化学 • 上一篇    下一篇

氨基酸羟胺钒配合物的合成、表征及对PTP1B酶的抑制活性

张恒强1, 张其颖1, 李佳2, 刘东1, 吴小芳1, 单永奎1   

  1. 1. 华东师范大学化学系, 上海 200062;
    2. 国家新药筛选中心, 上海 201203
  • 收稿日期:2011-05-12 出版日期:2012-02-10 发布日期:2012-01-13
  • 通讯作者: 单永奎, 男, 博士, 教授, 博士生导师, 主要从事催化和生物无机化学研究, E-mail: ykshan@chem.ecnu.edu.cn E-mail:ykshan@chem.ecnu.edu.cn
  • 基金资助:

    上海市科学技术委员会基础研究重点项目(批准号: 11JC1403400, 08JC1408600)资助.

Synthesis, Characterization and PTP1B Inhibitory Activity of the Vanadium Complexes with Amino-acids

ZHANG Heng-Qiang1, ZHANG Qi-Ying1, LI Jia2, LIU Dong1, WU Xiao-Fang1, SHAN Yong-Kui1   

  1. 1. Department of Chemsitry, East China Normal University, Shanghai 200062, China;
    2. National Center for Drug Screening, Shanghai 201203, China
  • Received:2011-05-12 Online:2012-02-10 Published:2012-01-13

摘要: 合成了2种羟胺氧钒配合物——缬(亮)氨酸羟胺氧钒, 并通过元素分析、红外光谱、紫外光谱、热重分析及X射线单晶衍射对其结构进行了表征. 采用PTP1B酶筛选模型评价了它们及相关配合物的PTP1B酶抑制活性. 实验结果表明, 这2种配合物同属于三斜晶系, P1空间群, 中心钒原子与7个配位的氮氧原子形成扭曲的五角双锥构型, 进而通过氢键作用形成三维晶体结构. 这2种配合物对PTP1B酶都表现出抑制活性, 亮氨酸羟胺氧钒在浓度为20 μg/mL时对PTP1B酶的抑制率达到90.51%.

关键词: 氨基酸羟胺氧钒配合物, 晶体结构, PTP1B酶抑制活性

Abstract: Two vanadium-amino acid-hydroxylamido complexes,[VO(NH2O)2(C5H10O2N] (1) and K[VO(NH2O)2(C6H12NO2N]2Cl·H2O(2) were synthesized. Their structures and components were characterized by elemental analysis, IR spectrometry, UV-Vis spectrometry, thermal analysis and X-ray single crystal diffraction and their PTP1B inhibitory activities were also explored. Complexes 1 and 2 both crystallize in triclinic system with space group P1. The central vanadium and seven coordinated atoms form a distorted pentagonal bipyramidal. Two O atoms and three N atoms from hydroxylamine and amino-acids define an equatorial plane approximately perpendicular to V=O. The N of hydroxylamine is cis to N of amino-acids and the O of amino-acids is trans to V=O. Complex 2 displays a good inhibitory activity against PTP1B(inhibition rate is 90.51% at 20 μg/mL).

Key words: Vanadium-amino acid-hydroxylamido complex, Crystal structure, PTP1B inhibitory activity

中图分类号: 

TrendMD: